Rani-Logo.jpg
Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results
March 15, 2024 16:05 ET | Rani Therapeutics, LLC
SAN JOSE, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Vivtex logo.png
Vivtex Enters Research Collaboration with Astellas Pharma
January 23, 2024 09:00 ET | Vivtex
Cambridge, MA, USA and Zurich, Switzerland – 23rd January 2024. Vivtex Corporation (“Vivtex” or “the Company”), a biotech company aiming to transform the development of oral biologic therapies for...
Vivtex logo.png
Vivtex and AI Proteins Enter Strategic R&D Collaboration to Develop Novel, Oral Biologic Therapies for Inflammatory Diseases
January 18, 2024 09:00 ET | Vivtex
Cambridge/Boston, MA, USA – 18th January 2024. Vivtex Corporation (“Vivtex”), a biotech company aiming to transform the development of oral biologic therapies for major diseases, and AI Proteins,...